Cargando…

Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19

BACKGROUND: Corona Virus Disease 2019 (COVID-19) and Osteoarthritis (OA) are diseases that seriously affect the physical and mental health and life quality of patients, particularly elderly patients. However, the association between COVID-19 and osteoarthritis at the genetic level has not been inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yiwei, Duan, Zhengwei, Guan, Yonghao, Xu, Tianyang, Fu, Yuesong, Li, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239847/ https://www.ncbi.nlm.nih.gov/pubmed/37283761 http://dx.doi.org/10.3389/fimmu.2023.1167639

Ejemplares similares

Editorial: Platelets as Players in Neuropathologies: Novel Diagnostic and Therapeutic Targets
por: Wassmer, Samuel C., et al.
Publicado: (2021)

Single-cell protein activity analysis reveals a novel subpopulation of chondrocytes and the corresponding key master regulator proteins associated with anti-senescence and OA progression
por: Guang, Zhao, et al.
Publicado: (2023)

Quantitative Proteomic Profile of Psoriatic Epidermis Identifies OAS2 as a Novel Biomarker for Disease Activity
por: Zhou, Yuan, et al.
Publicado: (2020)

Endomembrane targeting of human OAS1 p46 augments antiviral activity
por: Soveg, Frank W, et al.
Publicado: (2021)

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
por: Sae-fung, Apiwit, et al.
Publicado: (2023)

Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging
por: Li, Deling, et al.
Publicado: (2020)

Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target
por: Ponce de León, Candelaria, et al.
Publicado: (2021)

Genome-Wide Identification of Target Genes for the Key B Cell Transcription Factor Ets1
por: Saelee, Prontip, et al.
Publicado: (2017)

Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus
por: Shen, Mengjia, et al.
Publicado: (2022)

Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases
por: Xie, Xiaofeng, et al.
Publicado: (2023)

Extracellular Vesicles and Interleukins: Novel Frontiers in Diagnostic and Therapeutic for Cancer
por: Souza, Aline G., et al.
Publicado: (2022)

Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
por: Dayakar, Alti, et al.
Publicado: (2019)

Novel potential therapeutic targets of alopecia areata
por: Xu, Wen, et al.
Publicado: (2023)

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer
por: Yang, Runyu, et al.
Publicado: (2023)

Complement C1s as a diagnostic marker and therapeutic target: Progress and propective
por: Ye, Jun, et al.
Publicado: (2022)

Is hemolysis a novel therapeutic target in COVID-19?
por: Ousaka, Daiki, et al.
Publicado: (2022)

Immunological characterization of stroke-heart syndrome and identification of inflammatory therapeutic targets
por: Zheng, Junyi, et al.
Publicado: (2023)

Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
por: Hasankhani, Aliakbar, et al.
Publicado: (2021)

Identification and validation of key biomarkers based on RNA methylation genes in sepsis
por: Zhang, Qianqian, et al.
Publicado: (2023)

Molecular Mechanisms for the Adaptive Switching Between the OAS/RNase L and OASL/RIG-I Pathways in Birds and Mammals
por: Rong, Enguang, et al.
Publicado: (2018)

Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization
por: Tian, Saisai, et al.
Publicado: (2021)

New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis
por: Nozaki, Yuji
Publicado: (2021)

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
por: Zhu, Manlian, et al.
Publicado: (2022)

Identification of SCRG1 as a Potential Therapeutic Target for Human Synovial Inflammation
por: Liu, Guoqiang, et al.
Publicado: (2022)

Identification of Key Pyroptosis-Related Genes and Distinct Pyroptosis-Related Clusters in Periodontitis
por: Ning, Wanchen, et al.
Publicado: (2022)

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
por: Zhou, Tao-tao, et al.
Publicado: (2023)

Identification of MARK2, CCDC71, GATA2, and KLRC3 as candidate diagnostic genes and potential therapeutic targets for repeated implantation failure with antiphospholipid syndrome by integrated bioinformatics analysis and machine learning
por: Zhang, Manli, et al.
Publicado: (2023)

Identification of novel clusters of co-expressing cytokines in a diagnostic cytokine multiplex test
por: Polley, Daniel J., et al.
Publicado: (2023)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
por: McBride, Margaret A., et al.
Publicado: (2021)

Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases
por: Ramprasath, Tharmarajan, et al.
Publicado: (2021)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
por: Zhai, Yujia, et al.
Publicado: (2021)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
por: Zhou, Xueyin, et al.
Publicado: (2022)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
por: Pal, Soumik, et al.
Publicado: (2022)

Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
por: Sallenave, Jean-Michel, et al.
Publicado: (2020)

Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
por: Zhang, Yujie, et al.
Publicado: (2020)

CNS-Spleen Axis – a Close Interplay in Mediating Inflammatory Responses in Burn Patients and a Key to Novel Burn Therapeutics
por: Khan, Noorisah, et al.
Publicado: (2021)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers
por: Wu, Gujie, et al.
Publicado: (2023)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95vk8gmf98cm019s81ti285o41